Morgan Stanley Maintains Underweight on Virtus Inv, Lowers Price Target to $125

Benzinga Newsdesk www.benzinga.com Negative 69.7%

Neg 69.7% Neu 0% Pos 0%

Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $155 to $125.